Trials / Sponsors / PepGen Inc
PepGen Inc
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE) Myotonic Dystrophy 1 | Phase 2 | 2025-12-23 |
| Withdrawn | A Study of PGN-EDO51 or Placebo in People With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatm Duchenne Muscular Dystrophy (DMD) | Phase 2 | 2024-12-17 |
| Recruiting | A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 Myotonic Dystrophy 1 | Phase 2 | 2024-12-10 |
| Terminated | A Study Of PGN-EDO51 In Participants With Duchenne Muscular Dystrophy Amenable To Exon 51-Skipping Treatment Duchenne Muscular Dystrophy | Phase 2 | 2024-01-03 |
| Completed | Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1 Myotonic Dystrophy 1 | Phase 1 | 2023-12-12 |